Mercer Global Advisors
FULC icon

Mercer Global Advisors’s Fulcrum Therapeutics FULC Stock Holding History

Mercer Global Advisors’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.3K Buy
+10,866
New +$101K ﹤0.01% 3058

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Mercer Global Advisors's FULC Position: Q1 2026 in Review

Mercer Global Advisors opened a new position in Fulcrum Therapeutics (FULC) in Q1 2026: 10,866 shares worth $83.3K. The stake represents ﹤0.01% of the portfolio and ranks #3058 among its holdings.

169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Mercer Global Advisors held 10,866 shares of Fulcrum Therapeutics worth $83.3K as of Q1 2026.
  • Fulcrum Therapeutics was a new Mercer Global Advisors position in Q1 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #3058 holding.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.